PDCD1 and neoplasm: Moreover, the inhibition of tyrosine kinases can enhance the function of T lymphocytes in the tumor microenvironment through anti-angiogenic effects, thereby enhancing the anti-tumor effect of anti-PD-1/PD-L1 antibodies (26).